Adient (NYSE:ADNT) Price Target Cut to $24.00 by Analysts at Barclays
Adient (NYSE:ADNT – Free Report) had its price objective trimmed by Barclays from $29.00 to $24.00 in a report issued on Thursday morning, Benzinga reports. The brokerage currently has an equal weight rating on the stock. Several other equities research analysts also recently weighed in on the company. UBS Group decreased their price target on […]
More Stories
Truvestments Capital LLC Buys New Position in BellRing Brands, Inc. (NYSE:BRBR)
Truvestments Capital LLC acquired a new position in BellRing Brands, Inc. (NYSE:BRBR – Free Report) during the 3rd quarter, HoldingsChannel.com...
Inter Parfums, Inc. (NASDAQ:IPAR) COO Pelayo Frederic Garcia Sells 4,000 Shares
Inter Parfums, Inc. (NASDAQ:IPAR – Get Free Report) COO Pelayo Frederic Garcia sold 4,000 shares of the stock in a...
Truvestments Capital LLC Invests $39,000 in Main Street Capital Co. (NYSE:MAIN)
Truvestments Capital LLC purchased a new position in shares of Main Street Capital Co. (NYSE:MAIN – Free Report) in the...
Truvestments Capital LLC Purchases Shares of 392 Target Co. (NYSE:TGT)
Truvestments Capital LLC purchased a new stake in Target Co. (NYSE:TGT – Free Report) during the 3rd quarter, according to...
Truvestments Capital LLC Takes Position in Fidelity Low Volatility Factor ETF (NYSEARCA:FDLO)
Truvestments Capital LLC purchased a new stake in shares of Fidelity Low Volatility Factor ETF (NYSEARCA:FDLO – Free Report) in...
Brown Brothers Harriman & Co. Has $247,000 Holdings in GSK plc (NYSE:GSK)
Brown Brothers Harriman & Co. lowered its stake in shares of GSK plc (NYSE:GSK – Free Report) by 18.3% during...